These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 27070911)

  • 21. Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.
    Carroll IM; Maharshak N
    World J Gastroenterol; 2013; 19(43):7531-43. PubMed ID: 24431894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.
    Li J; Butcher J; Mack D; Stintzi A
    Inflamm Bowel Dis; 2015 Jan; 21(1):139-53. PubMed ID: 25248007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of intestinal microbiota and microbiota-based treatments in IBD.
    Li Q; Zhou S; Wang Y; Cong J
    Arch Microbiol; 2022 Jul; 204(7):442. PubMed ID: 35776212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory bowel disease: factors involved in pathogenesis.
    Dudík B; Sepová HK; Bilková A
    Ceska Slov Farm; 2018; 67(3):95-100. PubMed ID: 30630325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch's postulates.
    Zhao H; Zhang W; Cheng D; You L; Huang Y; Lu Y
    Front Med (Lausanne); 2022; 9():1023896. PubMed ID: 36438062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.
    Abegunde AT; Muhammad BH; Bhatti O; Ali T
    World J Gastroenterol; 2016 Jul; 22(27):6296-317. PubMed ID: 27468219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases.
    Dolan KT; Chang EB
    Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27346644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
    Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.
    Liu S; Zhao W; Lan P; Mou X
    Protein Cell; 2021 May; 12(5):331-345. PubMed ID: 32601832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial pathogenesis in inflammatory bowel diseases.
    Kumar S; Kumar A
    Microb Pathog; 2022 Feb; 163():105383. PubMed ID: 34974120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IBD and the gut microbiota--from bench to personalized medicine.
    Bellaguarda E; Chang EB
    Curr Gastroenterol Rep; 2015 Apr; 17(4):15. PubMed ID: 25762474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping.
    Tomasello G; Mazzola M; Jurjus A; Cappello F; Carini F; Damiani P; Gerges Geagea A; Zeenny MN; Leone A
    J Biol Regul Homeost Agents; 2017; 31(1):245-249. PubMed ID: 28337900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
    Sitkin SI; Tkachenko EI; Vakhitov TY
    Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?
    Lira-Junior R; Figueredo CM
    World J Gastroenterol; 2016 Sep; 22(35):7963-72. PubMed ID: 27672291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative interactions with the microbiota: IBD.
    Salzman NH; Bevins CL
    Adv Exp Med Biol; 2008; 635():67-78. PubMed ID: 18841704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Putignani L; Del Chierico F; Vernocchi P; Cicala M; Cucchiara S; Dallapiccola B;
    Inflamm Bowel Dis; 2016 Feb; 22(2):487-504. PubMed ID: 26588090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.